Variant report
Variant | esv16868 |
---|---|
Chromosome Location | chr8:19854644-19855520 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:19845716..19848259-chr8:19851738..19854660,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2410620 | chr8:19854660-19854661 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs144679463 | chr8:19854681-19854682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2410621 | chr8:19854682-19854683 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs575711216 | chr8:19854690-19854691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192286405 | chr8:19854700-19854701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138428733 | chr8:19854707-19854708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148985667 | chr8:19854712-19854713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552775926 | chr8:19854737-19854738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369124528 | chr8:19854748-19854749 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2410622 | chr8:19854773-19854774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
11 | rs538531785 | chr8:19854778-19854779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556965462 | chr8:19854814-19854815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10217035 | chr8:19854819-19854820 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs183334784 | chr8:19854830-19854831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554704757 | chr8:19854844-19854845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188077207 | chr8:19854871-19854872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540014696 | chr8:19854883-19854884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2410623 | chr8:19854889-19854890 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs111865917 | chr8:19854909-19854910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577035467 | chr8:19854926-19854927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192522786 | chr8:19854935-19854936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547358177 | chr8:19854954-19854955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143756761 | chr8:19854975-19854976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530014466 | chr8:19854991-19854992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376595658 | chr8:19855000-19855001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17411113 | chr8:19855006-19855007 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs560372900 | chr8:19855007-19855008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527792583 | chr8:19855010-19855011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552447483 | chr8:19855024-19855025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78704858 | chr8:19855029-19855030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79734126 | chr8:19855030-19855031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184389042 | chr8:19855067-19855068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374667076 | chr8:19855127-19855128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73606088 | chr8:19855134-19855135 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs536246536 | chr8:19855175-19855176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73606089 | chr8:19855180-19855181 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs34564316 | chr8:19855221-19855222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs17411126 | chr8:19855272-19855273 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs189713177 | chr8:19855285-19855286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576953185 | chr8:19855303-19855304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192748605 | chr8:19855304-19855305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17411133 | chr8:19855331-19855332 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs17489373 | chr8:19855344-19855345 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs542661662 | chr8:19855349-19855350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541779595 | chr8:19855422-19855423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112752412 | chr8:19855465-19855466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184095702 | chr8:19855492-19855493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17091926 | chr8:19855497-19855498 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Melanoma | 20688739 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:19852400-19855000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:19852400-19855000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr8:19854200-19855800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr8:19854200-19856400 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr8:19855000-19855400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:19855000-19855400 | Enhancers | Brain Anterior Caudate | brain |
7 | chr8:19855000-19855800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr8:19855200-19856000 | Enhancers | Brain Substantia Nigra | brain |